Dataset Information


A Yellow Fever Virus 17D Infection and Disease Mouse Model Used to Evaluate a Chimeric Binjari-Yellow Fever Virus Vaccine.

ABSTRACT: Despite the availability of an effective, live attenuated yellow fever virus (YFV) vaccine (YFV 17D), this flavivirus still causes up to ?60,000 deaths annually. A number of new approaches are seeking to address vaccine supply issues and improve safety for the immunocompromised vaccine recipients. Herein we describe an adult female IFNAR-/- mouse model of YFV 17D infection and disease that recapitulates many features of infection and disease in humans. We used this model to evaluate a new YFV vaccine that is based on a recently described chimeric Binjari virus (BinJV) vaccine technology. BinJV is an insect-specific flavivirus and the chimeric YFV vaccine (BinJ/YFV-prME) was generated by replacing the prME genes of BinJV with the prME genes of YFV 17D. Such BinJV chimeras retain their ability to replicate to high titers in C6/36 mosquito cells (allowing vaccine production), but are unable to replicate in vertebrate cells. Vaccination with adjuvanted BinJ/YFV-prME induced neutralizing antibodies and protected mice against infection, weight loss and liver pathology after YFV 17D challenge.

PROVIDER: S-EPMC7564786 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC8781009 | BioStudies
| S-EPMC7564101 | BioStudies
| S-EPMC8105366 | BioStudies
| S-EPMC7349994 | BioStudies
| S-EPMC7300350 | BioStudies
2011-01-01 | S-EPMC3170363 | BioStudies
2017-01-01 | S-EPMC5559630 | BioStudies
| S-EPMC7157777 | BioStudies
| S-EPMC6709925 | BioStudies
| S-EPMC4811652 | BioStudies